A ban on diversity, equity, and inclusion (DEI) initiatives may be affecting the clinical research ecosystem. There is concern that this ban could dismantle diversity initiatives in clinical trials and have a negative impact on certain areas of research, such as Alzheimer's trials. The full effects of the ban and related policy shifts on healthcare and clinical research are uncertain.